Stockreport

Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment

Moleculin Biotech, Inc.  (MBRX) 
Last moleculin biotech, inc. earnings: 8/16 05:35 pm Check Earnings Report
US:NASDAQ Investor Relations: moleculin.com/investors
PDF Presented data highlights the potential of Annamycin for treating broad range of human cancers, including high-need oncology indications  Annamycin currently in late-st [Read more]